Research Catalog

Title

Staff report on Sanofi's strategic use of third parties to influence the FDA [microform] / prepared by the staff of the Committee on Finance, United States Senate.

Publication

Washington : U.S. G.P.O., 2011.

Details

Additional Authors

United States. Congress. Senate. Committee on Finance.

Description

iii, 177 p.; 24 cm.

Series Statement

S. prt. ; 112-20

Uniform Title

S. prt ; 111-20.

Subject

• sanofi aventis (Firm) > Corrupt practices
• United States. Food and Drug Administration > Management
• Drug approval > Corrupt practices > United States
• Anticoagulants (Medicine) > Government policy > United States
• Generic drugs > Government policy > United States

Note

• At head of title: 112th Congress, 1st session. Committee print.
• Shipping list no.: 2011-0324-M.
• Paper version available for sale by the Supt. of Docs., U.S. G.P.O.
• "May 2011."

Bibliography (note)

• Includes bibliographical references.

Reproduction (note)

• Microfiche.

Call Number

GPO Microfiche Y 4.F 49:S.PRT.112-20

OCLC

marcive756681834

Title

Staff report on Sanofi's strategic use of third parties to influence the FDA [microform] / prepared by the staff of the Committee on Finance, United States Senate.

Imprint

Washington : U.S. G.P.O., 2011.

Series

S. prt. ; 112-20

S. prt ; 111-20.

Bibliography

Includes bibliographical references.

Reproduction

Microfiche. [Washington, D.C.] : Supt. of Docs., U.S. G.P.O., [2011]. 2 microfiches : negative.

Added Author

United States. Congress. Senate. Committee on Finance.

Other Form:

Print version: Staff report on Sanofi's strategic use of third parties to influence the FDA (OCoLC)738404763

Online version: Staff report on Sanofi's strategic use of third parties to influence the FDA (OCoLC)741958525

Gpo Item No.

1038-B (MF)

Sudoc No.

Y 4.F 49:S.PRT.112-20